2017-02-07 13:02:49 UTC

Tools for Management of C. Diff in IBD

Feb. 9, 2017

AGA Clinical Practice Update, patient guide and community discussion will help you in the treatment of C. diff in IBD.

The latest AGA Clinical Practice Update (CPU) is on the management of Clostridium difficile, or C. diff, infection in inflammatory bowel disease (IBD) patients and provides direction from the AGA CPU Committee for the management of patients with both. You can read the expert review in Clinical Gastroenterology and Hepatology.

  • For you: Andrea Shin, MD, started a discussion and poll in the AGA Community forum to test your knowledge on how to treat C. diff in IBD, using the CPU best-practice advice. Dr. Shin shared the multiple-choice case question in the forum and will provide the correct answer with explanation when the poll closes on Tuesday, Feb. 14.
  • For your patients: In connection with the CPU, AGA created a guide to share with your IBD patients to help them better understand treatment options if they have been diagnosed with C. diff.

Following the poll, the discussion will open as an eQ&A session for your questions and concerns around treating C. diff infection in IBD patients. Take the poll today and then bring your questions to Dr. Shin.

More on Clostridium difficile infection

IBD: When C. Diff Strikes

April 4, 2017

Gut dysbiosis predisposes patients to infection. Read more in this AGA-MedPage Today Reading Room article.

What is the Active Ingredient in FMT for C. diff Infection?

March 14, 2017

Sterile fecal filtrates — containing bacterial debris, proteins, antimicrobial compounds, metabolic products and microbial DNA, rather than intact microorganisms — appear to be effective.

IBD 110: Clostridium Difficile (C. Diff) in IBD Patients

Feb. 8, 2017

This patient guide will help patients with IBD diagnosed with C. diff better understand the treatment options that are available for them.